Solitron Devices Financials

Solitron Devices Stock Summary

Solitron Devices competes with NRx Pharmaceuticals, Aerovate Therapeutics, Akari Therapeutics, Armata Pharmaceuticals, and Anebulo Pharmaceuticals. Solitron Devices, Inc. designs, develops, manufactures, and markets solid-state semiconductor components and related devices primarily for the military and aerospace markets. The company was incorporated in 1959 and is headquartered in West Palm Beach, Florida. Solitron Devices operates under Semiconductor Equipment Materials classification in the United States and is traded on OTC Exchange. It employs 54 people.

Solitron Devices Key Financial Ratios

Solitron Devices' financial ratios allow both analysts and investors to convert raw data from Solitron Devices' financial statements into concise, actionable information that can be used to evaluate the performance of Solitron Devices over time and compare it to other companies across industries.

Solitron Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Solitron Devices's current stock value. Our valuation model uses many indicators to compare Solitron Devices value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Solitron Devices competition to find correlations between indicators driving Solitron Devices's intrinsic value. More Info.Solitron Devices is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Solitron Devices by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Solitron Devices' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Solitron Devices Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Solitron Devices help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Solitron Devices. We use our internally-developed statistical techniques to arrive at the intrinsic value of Solitron Devices based on widely used predictive technical indicators. In general, we focus on analyzing Solitron Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Solitron Devices's daily price indicators and compare them against related drivers.

When running Solitron Devices' price analysis, check to measure Solitron Devices' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solitron Devices is operating at the current time. Most of Solitron Devices' value examination focuses on studying past and present price action to predict the probability of Solitron Devices' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solitron Devices' price. Additionally, you may evaluate how the addition of Solitron Devices to your portfolios can decrease your overall portfolio volatility.